The conference “Biosimilars: value-based management” was recently held in Valencia, which aimed to delve into the main challenges of managing biosimilar therapies, as well as their contribution, present and future, to the sustainability of the health system.
The general director of BioSim, Encarna Cruz, gave the presentation “Biosimilars, challenges and opportunities”, and participated in the table on “Biosimilars, what have we learned? What can we improve?”
